Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases

Introduction. The possible risk factors for chronic kidney disease in transplant recipients have not been thoroughly investigated after living-donor liver transplantation. Material and Methods. A retrospective cohort study of consecutive adults who underwent living-donor liver transplantation betwee...

Full description

Saved in:
Bibliographic Details
Main Authors: Ehab E. Abdel-Khalek, Alrefaey K. Alrefaey, Amr M. Yassen, Ahmed Monier, Hesham M. Elgouhari, Mohamed Samy Habl, Gehad Tawfik, Thuraya Elzayat, Reham Adly Zayed, Mohamed Abdel-Wahab
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2018/5910372
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559197234921472
author Ehab E. Abdel-Khalek
Alrefaey K. Alrefaey
Amr M. Yassen
Ahmed Monier
Hesham M. Elgouhari
Mohamed Samy Habl
Gehad Tawfik
Thuraya Elzayat
Reham Adly Zayed
Mohamed Abdel-Wahab
author_facet Ehab E. Abdel-Khalek
Alrefaey K. Alrefaey
Amr M. Yassen
Ahmed Monier
Hesham M. Elgouhari
Mohamed Samy Habl
Gehad Tawfik
Thuraya Elzayat
Reham Adly Zayed
Mohamed Abdel-Wahab
author_sort Ehab E. Abdel-Khalek
collection DOAJ
description Introduction. The possible risk factors for chronic kidney disease in transplant recipients have not been thoroughly investigated after living-donor liver transplantation. Material and Methods. A retrospective cohort study of consecutive adults who underwent living-donor liver transplantation between May 2004 and October 2016, in a single center, was conducted. Kidney function was investigated successively for all the patients throughout the study period, with 12 months being the shortest follow-up. Postoperative renal dysfunction was defined in accordance with the Chronic Kidney Disease Epidemiology Collaboration criteria. The patients’ demographic data, preoperative and intraoperative parameters, and outcomes were recorded. A calcineurin inhibitor-based immunosuppressive regimen, either tacrolimus or cyclosporine, was used in all the patients. Results. Of the 413 patients included in the study, 33 (8%) who survived for ≥1 year experienced chronic kidney disease 1 year after living-donor liver transplantation. Twenty-seven variables were studied to compare between the patients with normal kidney functions and those who developed chronic kidney disease 1 year after living-donor liver transplantation. Univariate regression analysis for predicting the likelihood of chronic kidney disease at 1 year revealed that the following 4 variables were significant: operative time, P < 0.0005; intraoperative blood loss, P < 0.0005; preoperative renal impairment, P = 0.001; and graft-to-recipient weight ratio (as a negative predictor), P < 0.0005. In the multivariate regression analysis, only 2 variables remained as independent predictors of chronic kidney disease at 1 year, namely, operative time with a cutoff value of ≥714 minutes and graft-to-recipient weight ratio as a negative predictor with a cutoff value of <0.91. Conclusion. In this study, prolonged operative time and small graft-to-recipient weight ratio were independent predictors of chronic kidney disease at 1 year after living-donor liver transplantation.
format Article
id doaj-art-3231b293c8d14f3681e0474a09298fe9
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-3231b293c8d14f3681e0474a09298fe92025-02-03T01:30:34ZengWileyJournal of Transplantation2090-00072090-00152018-01-01201810.1155/2018/59103725910372Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 CasesEhab E. Abdel-Khalek0Alrefaey K. Alrefaey1Amr M. Yassen2Ahmed Monier3Hesham M. Elgouhari4Mohamed Samy Habl5Gehad Tawfik6Thuraya Elzayat7Reham Adly Zayed8Mohamed Abdel-Wahab9Liver Transplantation Unit and Department of Internal Medicine, Faculty of Medicine, University of Mansoura, Mansoura, EgyptDepartment of Anaesthesia and Surgical Intensive Care, Faculty of Medicine, University of Mansoura, Mansoura, EgyptDepartment of Anaesthesia and Surgical Intensive Care, Faculty of Medicine, University of Mansoura, Mansoura, EgyptLiver Transplantation Unit and Gastroenterology Center, Faculty of Medicine, University of Mansoura, Mansoura, EgyptDepartment of Internal Medicine, Sanford School of Medicine, University of South Dakota, USALiver Transplantation Unit and Department of Internal Medicine, Faculty of Medicine, University of Mansoura, Mansoura, EgyptHouse Officer, University of Mansoura, Mansoura, EgyptHouse Officer, University of Mansoura, Mansoura, EgyptLiver Transplantation Unit and Department of Internal Medicine, Faculty of Medicine, University of Mansoura, Mansoura, EgyptLiver Transplantation Unit and Gastroenterology Center, Faculty of Medicine, University of Mansoura, Mansoura, EgyptIntroduction. The possible risk factors for chronic kidney disease in transplant recipients have not been thoroughly investigated after living-donor liver transplantation. Material and Methods. A retrospective cohort study of consecutive adults who underwent living-donor liver transplantation between May 2004 and October 2016, in a single center, was conducted. Kidney function was investigated successively for all the patients throughout the study period, with 12 months being the shortest follow-up. Postoperative renal dysfunction was defined in accordance with the Chronic Kidney Disease Epidemiology Collaboration criteria. The patients’ demographic data, preoperative and intraoperative parameters, and outcomes were recorded. A calcineurin inhibitor-based immunosuppressive regimen, either tacrolimus or cyclosporine, was used in all the patients. Results. Of the 413 patients included in the study, 33 (8%) who survived for ≥1 year experienced chronic kidney disease 1 year after living-donor liver transplantation. Twenty-seven variables were studied to compare between the patients with normal kidney functions and those who developed chronic kidney disease 1 year after living-donor liver transplantation. Univariate regression analysis for predicting the likelihood of chronic kidney disease at 1 year revealed that the following 4 variables were significant: operative time, P < 0.0005; intraoperative blood loss, P < 0.0005; preoperative renal impairment, P = 0.001; and graft-to-recipient weight ratio (as a negative predictor), P < 0.0005. In the multivariate regression analysis, only 2 variables remained as independent predictors of chronic kidney disease at 1 year, namely, operative time with a cutoff value of ≥714 minutes and graft-to-recipient weight ratio as a negative predictor with a cutoff value of <0.91. Conclusion. In this study, prolonged operative time and small graft-to-recipient weight ratio were independent predictors of chronic kidney disease at 1 year after living-donor liver transplantation.http://dx.doi.org/10.1155/2018/5910372
spellingShingle Ehab E. Abdel-Khalek
Alrefaey K. Alrefaey
Amr M. Yassen
Ahmed Monier
Hesham M. Elgouhari
Mohamed Samy Habl
Gehad Tawfik
Thuraya Elzayat
Reham Adly Zayed
Mohamed Abdel-Wahab
Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
Journal of Transplantation
title Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
title_full Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
title_fullStr Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
title_full_unstemmed Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
title_short Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
title_sort renal dysfunction after living donor liver transplantation experience with 500 cases
url http://dx.doi.org/10.1155/2018/5910372
work_keys_str_mv AT ehabeabdelkhalek renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT alrefaeykalrefaey renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT amrmyassen renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT ahmedmonier renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT heshammelgouhari renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT mohamedsamyhabl renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT gehadtawfik renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT thurayaelzayat renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT rehamadlyzayed renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases
AT mohamedabdelwahab renaldysfunctionafterlivingdonorlivertransplantationexperiencewith500cases